Haru Invest Releases “Farming Just Got Easier”, Allowing Users to Invest as Liquidity Provider
SEOUL, REPUBLIC OF KOREA / ACCESSWIRE / December 16, 2021 / Haru Invest, a top…
SEOUL, REPUBLIC OF KOREA / ACCESSWIRE / December 16, 2021 / Haru Invest, a top…
VANCOUVER, BC / ACCESSWIRE / December 16, 2021 / Nepra Foods Inc. (“Nepra”) (CSE:NPRA)(FSE:2P6.F)(OTC PINK:NPRFF),…
VANCOUVER, BC / ACCESSWIRE / December 16, 2021 / Cielo Waste Solutions Corp. (TSXV:CMC; OTCQB:CWSFF)…
LOS ANGELES, CA / ACCESSWIRE / December 16, 2021 / Suzann Fakhoury, Vice President of…
VANCOUVER, BC / ACCESSWIRE / December 16, 2021 / LINK GLOBAL TECHNOLOGIES INC. (CSE:LNK)(FSE:LGT)(OTC PINK:LGLOF)…
TUCSON, AZ / ACCESSWIRE / December 16, 2021 / Investing in real estate is one…
Following Phase2b/SARA-INT clinically meaningful results, Biophytis is starting first regulatory activities to advance from Phase…
LONDON, December 16, 2021: London law firm Marriott Harrison (“MH”) has announced Katerina Heal has…
Oxford University spin-out’s indoor location-based platform adds to last year’s $11M Series A investment to…
The US Orphan Drug Designation would provide seven-year market exclusivity if Visomitin was approved for…
Study Supports Ongoing Phase 3 Program and Planned NDA Submission LONDON and RALEIGH, N.C., Dec….
VIENNA, Austria, Dec. 16, 2021 (GLOBE NEWSWIRE) — invIOs (innovative Immuno-Oncology) GmbH, a privately held…
– Leading international syndicate led by Forbion and corner-stoned by founding investor Syncona– Confirms depth…
InnoSkel awarded Innovation Passport by the UK MHRA for the treatment of a rare bone…
Company announcement – No. 76 / 2021 Zealand Pharma Announces Enrollment of Last Patient Needed…
Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development…
Gilles SCHNEPP takes over as Chairman of the Appointments, Governance and CSR Committee…
Press Release Nicox Announces First Patient in China screened in the ongoing NCX 470…
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8…
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…